Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose theophylline added to inhaled corticosteroids for prevention of COPD exacerbations
2013-001490-25Phase 3Completed
- Sponsor
- University of Aberdeen
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Theophylline plus inhaled corticosteroids with Placebo plus inhaled corticosteroids (2 arms). Primary endpoints: Total number of COPD exacerbations requiring treatment change and Cost per QALY gained during 1 year. Started Aug 2013; status: completed.
02
Drugs
theophylline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2013-001490-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001490-25.